{"id":118668,"date":"2024-02-06T15:38:17","date_gmt":"2024-02-06T10:08:17","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=118668"},"modified":"2024-02-06T17:02:52","modified_gmt":"2024-02-06T11:32:52","slug":"stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/","title":{"rendered":"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2390624210\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2089638297\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalisation of Rs. 2,629 crores, the shares of IOL Chemicals and Pharmaceuticals Ltd started Tuesday\u2019s trading session on a higher note at Rs. 439 compared to its previous close of Rs. 437.80. <\/p><p>During the trading session, the shares hit a high of Rs. 452, gaining around 3 percent and are currently trading at Rs. 447 apiece.\u00a0<\/p><p>Such a positive movement in the share was observed after the company in an exchange filing announced that on 5th February 2024, the European Directorate for the Quality of Medicines and Health Care (EDQM) issued a Certificate of Suitability for Losartan Potassium.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1704219707\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>This will enable the company to export Losartan Potassium to the European Market. Moreover, Losartan is a drug used for the treatment of hypertension.&nbsp;<\/p><p>Looking at the company\u2019s financial statement, the revenue decreased marginally by 3 percent from Rs. 563 crores in the June quarter to Rs. 545 crores during the September quarter. In addition, the net profits declined by around 18 percent from Rs. 46 crores to Rs. 38 crores during the same timeframe.&nbsp;<\/p><p>The company has earmarked an annual capex of Rs 150 to 200 crores for the next few years, with specific investments in expanding the capacity of its Ibuprofen plant and ramping up the production capacity of ethyl acetate.&nbsp;<\/p><p>Additionally, the company has planned new manufacturing facilities and projects for manufacturing multiple pharma (APIs) products, with an aggregate capex of about Rs. 90 crores.&nbsp;<\/p><p>Headquartered in Ludhiana, IOL Chemicals and Pharmaceuticals was incorporated in 1986. The company is a leading pharmaceutical (APIs) company and is a significant player in the speciality chemicals space. It serves the domestic and export markets. It is the largest player in Ibuprofen (pain killer) globally with a world market share of 35 percent.&nbsp;<\/p><p><strong>Written By Vaibhav Patil&nbsp;<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-1693994942\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2521229355\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.&nbsp; With a market capitalisation of Rs. 2,629 crores, the shares [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,13525],"tags":[],"class_list":["post-118668","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-stock-updates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market\" \/>\n<meta property=\"og:description\" content=\"Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-06T10:08:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-06T11:32:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/\",\"url\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/\",\"name\":\"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-02-06T10:08:17+00:00\",\"dateModified\":\"2024-02-06T11:32:52+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market - Trade Brains Features","description":"Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/","og_locale":"en_US","og_type":"article","og_title":"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market","og_description":"Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-02-06T10:08:17+00:00","article_modified_time":"2024-02-06T11:32:52+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/","url":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/","name":"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-02-06T10:08:17+00:00","dateModified":"2024-02-06T11:32:52+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of this pharmaceutical company jumped 3 percent in Tuesday\u2019s trading session after receiving a Certificate of Suitability from the European Directorate for the Quality of Medicines and Health Care (EDQM). In one year, the shares have delivered more than 40 percent to its shareholders.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/stock-jumps-3-after-receiving-certificate-to-export-losartan-potassium-to-european-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Stock jumps 3% after receiving certificate\u00a0to export losartan potassium to European Market"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/118668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=118668"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/118668\/revisions"}],"predecessor-version":[{"id":118669,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/118668\/revisions\/118669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=118668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=118668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=118668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}